Genetic Technologies (STU:DU8) EBITDA Margin % : 0.00% (As of Dec. 2023)

Genetic Technologies EBITDA Margin % Chart

Genetic Technologies Annual Data
	Trend	Jun14	Jun15	Jun16	Jun17	Jun18	Jun19	Jun20	Jun21	Jun22	Jun23
EBITDA Margin %		Get a 7-Day Free Trial					-26,246.67	-60,916.67	-5,501.30	-96.68	-128.97

Genetic Technologies Quarterly Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBITDA Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Genetic Technologies's EBITDA Margin %

For the Diagnostics & Research subindustry, Genetic Technologies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genetic Technologies's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Technologies's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Genetic Technologies's EBITDA Margin % falls into.

Genetic Technologies EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Genetic Technologies's EBITDA Margin % for the fiscal year that ended in Jun. 2023 is calculated as

Genetic Technologies's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genetic Technologies  (STU:DU8) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Genetic Technologies EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Genetic Technologies's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Technologies (STU:DU8) Business Description